...
首页> 外文期刊>The Lancet >Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial.
【24h】

Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial.

机译:常规预防性补充铁和叶酸对尼泊尔南部学龄前儿童死亡率的影响:基于社区的整群随机安慰剂对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Iron deficiency is widespread in the developing world and is especially common in young children who live on the Indian subcontinent. Supplementation with iron and folic acid alleviates severe anaemia and enhances neurodevelopment in deficient populations, but little is known about the risks of mortality and morbidity associated with supplementation. METHODS: We did a community-based, cluster-randomised, double-masked, placebo-controlled, 2x2 factorial trial in children aged 1-36 months and residing in southern Nepal. We randomly assigned children daily oral supplementation to age 36 months with: iron (12.5 mg) and folic acid (50 microg; n=8337), zinc alone (10 mg), iron, folic acid, and zinc (n=9230), or placebo (n=8683); children aged 1-11 months received half the dose. Our primary outcome measure was all-cause mortality, and our secondary outcome measures included cause-specific mortality and incidence and severity of diarrhoea, dysentery, and acute respiratory illness. Analyses were by intention to treat. This study is registered at , number NCT00109551. FINDINGS: The iron and folic acid-containing groups of the study were stopped early in November, 2003, on the recommendation of the data and safety monitoring board; mortality in these groups did not differ from placebo and there was low power to detect positive or negative effects by the time enrollment was completed. We continued to enroll children to the placebo and zinc alone groups. 25,490 children participated and analyses are based on 29,097.3 person-years of follow-up. There was no difference in mortality between the groups who took iron and folic acid without or with zinc when compared with placebo (HR 1.03, 95 CI 0.78-1.37, and 1.00, 0.74-1.34, respectively). There were no significant differences in the attack rates for diarrhoea, dysentery, or respiratory infections between groups, although all the relative risks except one indicated modest, non-significant protective effects. INTERPRETATION: Daily supplementation of young children in southern Nepal with iron and folic acid with or without zinc has no effect on their risk of death, but might protect against diarrhoea, dysentery, and acute respiratory illness.
机译:引言:缺铁在发展中国家很普遍,在生活在印度次大陆的幼儿中尤为常见。补充铁和叶酸可缓解严重贫血并促进缺乏人群的神经发育,但对与补充相关的死亡和发病风险知之甚少。方法: 我们在居住在尼泊尔南部的 1-36 个月大的儿童中进行了一项基于社区的、整群随机的、双盲的、安慰剂对照的 2x2 析因试验。我们将每日口服补充剂的儿童随机分配到36个月大,包括:铁(12.5毫克)和叶酸(50微克;n=8337),单独锌(10毫克),铁,叶酸和锌(n=9230)或安慰剂(n=8683);1-11个月的儿童接受了一半的剂量。我们的主要结局指标是全因死亡率,其次要结局指标包括特定原因的死亡率以及腹泻、痢疾和急性呼吸道疾病的发生率和严重程度。分析是出于治疗的意图。本研究注册于 ,编号为 NCT00109551。结果:根据数据和安全监测委员会的建议,该研究的含铁和叶酸组于2003年11月初停止;这些组的死亡率与安慰剂没有差异,并且在完成入组时检测积极或消极影响的功效较低。我们继续将儿童纳入安慰剂组和纯锌组。25,490 名儿童参与,分析基于 29,097.3 人年的随访。与安慰剂相比,不含锌或含锌服用铁和叶酸组的死亡率没有差异(HR 1.03,95% CI 0.78-1.37 和 1.00,0.74-1.34)。两组之间腹泻、痢疾或呼吸道感染的发作率没有显著差异,尽管除1个风险外,所有相对风险均显示出适度的、不显著的保护作用。解释:尼泊尔南部的幼儿每天补充铁和叶酸(含或不含锌)对他们的死亡风险没有影响,但可以预防腹泻、痢疾和急性呼吸道疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号